IL5 and asthma: In summary, PT, CR and their combinational prescription have deep inhibitory effects on airway inflammation in a murine model of asthma and it was caused by suppression of Th2 cytokines (IL-4, IL-5, IL-13), IgE, eosinophil CCR3 expression in lung.